Immunotherapy has revolutionized the therapy landscape of non-small cell lung cancer, significantly prolonging the overall survival of advanced-stage patients. We hear from both doctors and patients about the importance of Immunotherapy research. Dr. Smith will discuss her research advancements, thanks to LCFA funding, and what needs to be done for research in the future.
In this inspiring Hope With Answers: Living With Lung Cancer episode, host Diane Mulligan sits down with Lysa Buonanno, a remarkable individual who has defied the odds and thrived while living with lung cancer. Lysa’s story serves as a beacon of hope for others facing similar challenges, showcasing the power of research and the impact of donations in extending lives.
Lysa, who has been on chemotherapy for five years, candidly shares her journey, acknowledging the difficult days but emphasizing the importance of living life to the fullest. She highlights the role of research in providing her with the opportunity to enjoy her life. And she encourages listeners to support lung cancer research, no matter the size of their donation. Lysa’s message resonates deeply, reminding us that every dollar counts and contributes to future breakthroughs.
Guests:
Dr. Kellie Smith, Associate Professor of Oncology at the Bloomberg Kimmel Institute for Cancer Immunotherapy at Johns Hopkins.
Lysa Buonanno is living with lung cancer and is a tireless advocate for LCFA.
Resources:
Diane and Lysa are joined by Jordan Sherman, who emphasizes the significance of donor-generated research grants in overcoming research hurdles faced by Dr. Kellie Smith. Together, they shed light on the remarkable progress made in lung cancer treatment and the hope it brings to patients and their families.
Throughout the episode, LCFA’s hopeful voice shines through, offering authoritative and informative insights into lung cancer research, treatment options, and clinical trials. The podcast also extends a supportive hand to patients and their loved ones, providing access to updated treatment information and scientific investigations.
It serves as a reminder that, with continued support and collaboration, we can make significant strides in the battle against lung cancer, offering hope and a brighter future for all those affected by this disease.
